₹23.90
+0.21 (+0.89%)
As of 22 Sept 2026, Beryl Drugs Ltd share price is ₹23.90. The stock opened at ₹23.90 and had closed at ₹23.69 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹15.92 and a high of ₹27.60. In terms of performance, Beryl Drugs Ltd share price has increased by 16.98% over the past six months and has increased by 3.91% over the last year.
Beryl Drugs Stock Price Chart
Beryl Drugs Ltd Overview
Market cap₹12 Crs
Volume1,508
Prev. Close₹23.69
Year range₹15.92 - ₹27.60
ISININE415H01017
About Beryl Drugs
Beryl Drugs is principally engaged in manufacturing of bulk drugs.
Beryl Drugs Ltd Historical Performance
1 Month Return4.82%
6 Month Return11.68%
3 Year Return8.69%
3 Month Return9.58%
1 Year Return6.65%
5 Year Return91.35%
Beryl Drugs Ltd Fundamentals
ROCE(TTM)7.56%
P/E Ratio (TTM)19.43
P/B Ratio1.23
Debt to Equity0.25
ROE4.30%
EPS (TTM)1.23
Dividend Yield0.00%
Book Value19.44
Profit Margin2.91%
Operating Margin4.94%
Beryl Drugs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 19.31 | 22.55 | 27.12 | 27.16 | 14.77 |
| EBITDA | 2.42 | 2.65 | 2.67 | 2.21 | 0.58 |
| Net Profit | 0.42 | 0.58 | 0.77 | 0.77 | -0.66 |
| EPS | 0.84 | 1.14 | 1.52 | 1.52 | -1.30 |
Beryl Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 22.69 |
| Resistance 1 (R1) | 24.29 |
| Pivot Point | 23.30 |
Beryl Drugs Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Sudhir Sethi | Chairman |
| Sanjay Sethi | Managing Director |
| Abhinav Naik | Non Executive Independent Director |
Beryl Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Beryl Drugs Ltd today is ₹23.90 on NSE and ₹23.90 on BSE.
- The 52-week high of Beryl Drugs Ltd is ₹27.60, while the 52-week low is ₹15.92.
- The current market capitalisation of Beryl Drugs Ltd is approximately ₹12 crore.
- The P/E (Price-to-Earnings) ratio of Beryl Drugs Ltd is 19.43. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Beryl Drugs Ltd is 1.23. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Beryl Drugs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Beryl Drugs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Beryl Drugs Ltd has delivered a return of approximately 8.69%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Beryl Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 27.82% promoters, 0.00% FIIs, 0.00% DIIs, and 63.56% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
